뒤로
Genetic Technologies Limited(GNTLF) 가격
GNTLF 주가 차트
GNTLF 재무
Genetic Technologies Limited
$1
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$1
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
GNTLF 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Genetic Technologies Limited의 주요 재무제표는 무엇인가요?
GNTLF의 주요 재무 비율은 무엇인가요?
Genetic Technologies Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Genetic Technologies Limited은 수익성이 있나요?
Genetic Technologies Limited에 부채가 있나요?
Genetic Technologies Limited의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$1
시가
$1
일일 범위
$1 - $1
52주 범위
$1 - $1
거래량
100
평균 거래량
0
EPS(TTM)
-0.06
배당수익률
--
시가총액
$145.4M
GENETIC TECHNOLOGIES란 무엇인가요?
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.